scholarly journals Validation of extravascular lung water measurement by single transpulmonary thermodilution: human autopsy study

Critical Care ◽  
2010 ◽  
Vol 14 (5) ◽  
pp. R162 ◽  
Author(s):  
Takashi Tagami ◽  
Shigeki Kushimoto ◽  
Yasuhiro Yamamoto ◽  
Takahiro Atsumi ◽  
Ryoichi Tosa ◽  
...  
Keyword(s):  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Autopsy Study ◽  
Lung Water ◽  
Water Measurement ◽  
Human Autopsy

Validation of Extravascular Lung Water Measurement by Transpulmonary Thermodilution in a Pediatric Animal Model

2014 ◽  
Vol 15 (5) ◽  
pp. e226-e233 ◽  
Author(s):  
Anneliese Nusmeier ◽  
Sabine Vrancken ◽  
Willem P. de Boode ◽  
Johannes G. van der Hoeven ◽  
Joris Lemson
Keyword(s):  
Animal Model ◽  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Lung Water ◽  
Water Measurement

Extravascular lung water measurement using transpulmonary thermodilution in children

2009 ◽  
Vol 10 (2) ◽  
pp. 227-233 ◽  
Author(s):  
Joris Lemson ◽  
Ad P. Backx ◽  
Anton M. van Oort ◽  
Tijn P. W. J. M. Bouw ◽  
Johannes G. van der Hoeven
Keyword(s):  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Lung Water ◽  
Water Measurement

scholarly journals COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study

Critical Care ◽  
2021 ◽  
Vol 25 (1) ◽  
Author(s):  
Rui Shi ◽  
Christopher Lai ◽  
Jean-Louis Teboul ◽  
Martin Dres ◽  
Francesca Moretto ◽  
...  
Keyword(s):  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Diffuse Alveolar Damage ◽  
Lung Mechanics ◽  
Arterial Oxygen ◽  
Prone Positioning ◽  
University Hospitals ◽  
Lung Water ◽  
Pulmonary Vascular Permeability ◽  
Water Index

Abstract Background In acute respiratory distress syndrome (ARDS), extravascular lung water index (EVLWi) and pulmonary vascular permeability index (PVPI) measured by transpulmonary thermodilution reflect the degree of lung injury. Whether EVLWi and PVPI are different between non-COVID-19 ARDS and the ARDS due to COVID-19 has never been reported. We aimed at comparing EVLWi, PVPI, respiratory mechanics and hemodynamics in patients with COVID-19 ARDS vs. ARDS of other origin. Methods Between March and October 2020, in an observational study conducted in intensive care units from three university hospitals, 60 patients with COVID-19-related ARDS monitored by transpulmonary thermodilution were compared to the 60 consecutive non-COVID-19 ARDS admitted immediately before the COVID-19 outbreak between December 2018 and February 2020. Results Driving pressure was similar between patients with COVID-19 and non-COVID-19 ARDS, at baseline as well as during the study period. Compared to patients without COVID-19, those with COVID-19 exhibited higher EVLWi, both at the baseline (17 (14–21) vs. 15 (11–19) mL/kg, respectively, p = 0.03) and at the time of its maximal value (24 (18–27) vs. 21 (15–24) mL/kg, respectively, p = 0.01). Similar results were observed for PVPI. In COVID-19 patients, the worst ratio between arterial oxygen partial pressure over oxygen inspired fraction was lower (81 (70–109) vs. 100 (80–124) mmHg, respectively, p = 0.02) and prone positioning and extracorporeal membrane oxygenation (ECMO) were more frequently used than in patients without COVID-19. COVID-19 patients had lower maximal lactate level and maximal norepinephrine dose than patients without COVID-19. Day-60 mortality was similar between groups (57% vs. 65%, respectively, p = 0.45). The maximal value of EVLWi and PVPI remained independently associated with outcome in the whole cohort. Conclusion Compared to ARDS patients without COVID-19, patients with COVID-19 had similar lung mechanics, but higher EVLWi and PVPI values from the beginning of the disease. This was associated with worse oxygenation and with more requirement of prone positioning and ECMO. This is compatible with the specific lung inflammation and severe diffuse alveolar damage related to COVID-19. By contrast, patients with COVID-19 had fewer hemodynamic derangement. Eventually, mortality was similar between groups. Trial registration number and date of registration ClinicalTrials.gov (NCT04337983). Registered 30 March 2020—Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT04337983.

Extravascular Lung Water Measurement

2007 ◽  
pp. 549-559
Author(s):  
B. Maddison ◽  
T. Best ◽  
R. M. Pearse
Keyword(s):  
Extravascular Lung Water ◽  
Lung Water ◽  
Water Measurement

Transpulmonary Thermodilution Enables to Detect Small Short-Term Changes in Extravascular Lung Water Induced by a Bronchoalveolar Lavage

2014 ◽  
Vol 42 (8) ◽  
pp. 1869-1873 ◽  
Author(s):  
Martin Dres ◽  
Jean-Louis Teboul ◽  
Laurent Guerin ◽  
Nadia Anguel ◽  
Virginie Amilien ◽  
...  
Keyword(s):  
Bronchoalveolar Lavage ◽  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Short Term ◽  
Lung Water

Extravascular Lung Water Measurement During Ex Vivo Lung Perfusion

2014 ◽  
Vol 33 (4) ◽  
pp. S168 ◽  
Author(s):  
V. Linacre ◽  
M. Cypel ◽  
T. Machuca ◽  
D. Nakajima ◽  
K. Hashimoto ◽  
...  
Keyword(s):  
Extravascular Lung Water ◽  
Ex Vivo ◽  
Lung Perfusion ◽  
Lung Water ◽  
Ex Vivo Lung Perfusion ◽  
Water Measurement

scholarly journals Increased extravascular lung water index (EVLWI) reflects rapid inflammatory oedema and mortality in COVID-19 associated ARDS

2020 ◽  
Author(s):  
Sebastian Rasch ◽  
Paul Schmidle ◽  
Senguel Sancak ◽  
Alexander Herner ◽  
Christina Huberle ◽  
...  
Keyword(s):  
Pulmonary Oedema ◽  
Extravascular Lung Water ◽  
Transpulmonary Thermodilution ◽  
Control Group ◽  
Intensive Care Treatment ◽  
Lung Water ◽  
Pulmonary Vascular Permeability ◽  
Pulmonary Vascular Permeability Index ◽  
Extravascular Lung Water Index ◽  
Water Index

OBJECTIVE: Nearly 5 % of the patients with COVID-19 develop an acute respiratory distress syndrome (ARDS). Extravascular lung water index (EVLWI) is a marker of pulmonary oedema which is associated with mortality in ARDS. In this study we evaluate whether EVLWI is higher in patients with COVID-19 associated ARDS as compared to controls and whether EVLWI has the potential to monitor disease progression. METHODS: From the day of intubation, EVLWI, cardiac function were monitored by transpulmonary thermodilution in n=25 patients with COVID-19 and compared to a control group of 49 non-COVID-19 ARDS-patients. RESULTS: EVLWI in COVID-19-patients was noticeably elevated and significantly higher than in the control group (17 (11-38) vs. 11 (6-26) mL/kg; p<0.001). High pulmonary vascular permeability index values (2.9 (1.0-5.2) versus 1.9 (1.0-5.2); p=0.003) suggest inflammatory oedema. By contrast, the cardiac parameters SVI, GEF and GEDVI were comparable. High EVLWI values were associated with viral persistence, prolonged intensive care treatment and mortality (23.2±6.7% vs. 30.3±6.0%, p=0.025). CONCLUSIONS: Compared to the control group, COVID-19 results in markedly elevated EVLWI-values in patients with ARDS. EVLWI reflects a non-cardiogenic pulmonary oedema in COVID-19 associated ARDS and could serve as parameter to monitor ARDS progression.

Sign in / Sign up

Export Citation Format

Share Document